Nasser Bader Alsaleh

Dr. Nasser B. Alsaleh is an Associate Professor of Pharmacology and Toxicology at King Saud University and a specialist in molecular toxicology, nanotoxicology, and the safety assessment of advanced materials. He earned his PhD in Toxicology from the University of Colorado Anschutz Medical Campus, an MSc in Pharmaceutical Sciences from the University of Alberta, and a BPharm (Hons) from King Saud University. His doctoral research provided mechanistic insights into silver nanoparticle–mediated mast cell activation and immune responses to engineered nanomaterials, establishing a research program focused on understanding the health effects of advanced materials, particularly at low and subtoxic exposure levels. At King Saud University, Dr. Alsaleh founded and leads a molecular toxicology research team, established specialized laboratory infrastructure, and secured competitive funding for research on engineered nanomaterials and emerging therapeutic platforms. He has served as principal or co-investigator on projects totaling several million SAR, including studies evaluating nanomaterial safety and advanced nanomedicine applications, and has published more than 40 peer-reviewed articles while building collaborations across academic, healthcare, and regulatory sectors. Beyond laboratory research, he has contributed to strengthening the research and innovation environment at King Saud University through leadership in research strategy, graduate education, research groups, and institutional development, and chaired the scientific committee of the Saudi International Conference for Pharmaceutical Research and Innovation (MSIR). He also serves as Deputy Editor-in-Chief of the Saudi Pharmaceutical Journal and contributes to scientific and advisory committees within the Saudi Food and Drug Authority (SFDA), including committees related to chemical drug quality standards and cosmetic product safety. His work aligns closely with Saudi Arabia’s Health and Wellness research priorities through the safe and responsible development of advanced therapeutics and nanotechnologies, improved safety assessment and regulatory science, and national capacity building through education, mentorship, leadership, and collaboration. By integrating mechanistic toxicology, translational research, and institutional leadership, Dr. Alsaleh’s work supports the Kingdom’s ambition to advance innovative, safe, and sustainable healthcare solutions.

For further contact or to arrange a meeting, please contact me via email: nbalsaleh@ksu.edu.sa 

My research group is looking for graduate and PharmD students (graduation project track) for the academic year 2026-27. If you are interested, please share your CV and brief statement of research experience via email: nbalsaleh@ksu.edu.sa